News & AnalysisVariantyx lands $41.5mVariantyx, a technology-driven precision medicine company, has secured $41.5 million in funding.ByIris Dorbian14 February 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs